Laboratory Corporation Of America Holdings (LH): Today's Featured Health Services Loser

Laboratory Corporation of America Holdings ( LH) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole was unchanged today. By the end of trading, Laboratory Corporation of America Holdings fell $2.07 (-2.2%) to $92.55 on heavy volume. Throughout the day, 1.6 million shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 791,800 shares. The stock ranged in price between $92.23-$93.66 after having opened the day at $93.31 as compared to the previous trading day's close of $94.62. Other company's within the Health Services industry that declined today were: CombiMatrix Corporation ( CBMX), down 14.9%, Sunshine Heart ( SSH), down 14.8%, IsoRay ( ISR), down 14.6%, and Stereotaxis ( STXS), down 13.3%.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of diseases. Laboratory Corporation of America Holdings has a market cap of $9.22 billion and is part of the health care sector. The company has a P/E ratio of 17.3, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 10.8% year to date as of the close of trading on Monday. Currently there are seven analysts that rate Laboratory Corporation of America Holdings a buy, two analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Urologix ( ULGX), up 11.3%, ZELTIQ Aesthetics ( ZLTQ), up 7.1%, Misonix ( MSON), up 6.6%, and Trius Therapeutics ( TSRX), up 6.4%, were all gainers within the health services industry with UnitedHealth Group ( UNH) being today's featured health services industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Centene, LabCorp Among Healthcare Stock Gainers

Centene, LabCorp Among Healthcare Stock Gainers

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'

Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'

INC Research Holdings Seen as Likely LabCorp. Takeover Target

INC Research Holdings Seen as Likely LabCorp. Takeover Target

5 Big Stocks to Buy for Big Gains

5 Big Stocks to Buy for Big Gains